BioGaia
116,7
SEK
-0,17 %
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
-0,17%
+4,29%
+6,58%
+19,08%
-5,81%
+10,09%
+18,96%
+30,98%
+1.542,9%
BioGaia is a biotechnology company. The company develops, markets and sells probiotic products. The products are mainly based on the bacterium Lactobacillus, which has probiotic effects. Today, the company's products are sold around the global market. Research and development are conducted via the company's external network of research institutions and clinics. The head office is located in Stockholm.
Læs mereMarkedsværdi
11,81 mia. SEK
Aktieomsætning
22,17 mio. SEK
Omsætning
1,3 mia.
EBIT %
34,18 %
P/E
32,24
Udbytteafkast, %
5,91 %
Finanskalender
12.2
2025
Årsrapport '24
7.5
2025
Generalforsamling '25
7.5
2025
Delårsrapport Q1'25
ViserAlle indholdstyper
BioGaia launches a new probiotic supplement, BioGaia® Gastrus® PURE ACTION, designed for people with sensitive digestive systems
BioGaia, Audiocast with teleconference, Q3'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools